Morgan Stanley: Epistar 2Q Operating Margin Exceeds Initial Prediction

Epistar’s February 2014 revenue outperformed initial estimations, according to Morgan Stanley. Growing lighting demands drove up revenue and operating margin. Client orders in 2Q14 exceeded the company’s production capacity, which will be beneficial in improving its product portfolio and increasing product’s Average Selling Price (ASP).

The company’s consolidated revenue last month reached NT $1.98 billion (US $65.3 million), growth of 4.95 percent from January 2014 and 57.48 percent jump from February last year.

Epistar 2Q14 revenue is anticipated to reach NT $7.2 billion, a 20 percent QoQ increase or 18 percent growth from 2Q13, according to Morgan Stanley’s latest report.

Operating margin has continued to rise following profit improvements. Morgan Stanley anticipates Epistar to benefit from strong revenue and order performance. Overall profit increase is forecasted to bolster operating margin in 1Q14 by an estimated 5 percent and reach 11 percent by 2Q14, above the financial firm’s initial operating margin projections of 2.4 percent for 2013.

Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein<

Proprietary Rights
You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.